Karin Haustermans

Active 1997–2025

146
Papers
29,541
Citations
82
h-index
137
i10-index

Citations

Citations per year for Karin Haustermans1971: 1 citations1980: 1 citations1983: 1 citations1991: 1 citations1994: 1 citations1998: 4 citations1999: 10 citations2000: 26 citations2001: 13 citations2002: 20 citations2003: 22 citations2004: 34 citations2005: 35 citations2006: 54 citations2007: 66 citations2008: 62 citations2009: 62 citations2010: 75 citations2011: 110 citations2012: 99 citations2013: 156 citations2014: 182 citations2015: 159 citations2016: 167 citations2017: 217 citations2018: 216 citations2019: 993 citations2020: 1,133 citations2021: 1,054 citations2022: 724 citations2023: 553 citations2024: 1,047 citations2025: 448 citations2026: 20 citations1972–1979: no citations, so these years are not shown1981–1982: no citations, so these years are not shown1984–1990: no citations, so these years are not shown1992–1993: no citations, so these years are not shown1995–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,938 citing papers, 15.5% of this breakdownChina: 1,629 citing papers, 13% of this breakdownItaly: 921 citing papers, 7.4% of this breakdownGermany: 839 citing papers, 6.7% of this breakdownNetherlands: 739 citing papers, 5.9% of this breakdownUnited Kingdom: 731 citing papers, 5.8% of this breakdownFrance: 591 citing papers, 4.7% of this breakdownJapan: 468 citing papers, 3.7% of this breakdownSpain: 405 citing papers, 3.2% of this breakdownBelgium: 404 citing papers, 3.2% of this breakdownCanada: 344 citing papers, 2.7% of this breakdownSwitzerland: 321 citing papers, 2.6% of this breakdown
0%15.5%Other 25.6%

Fields

  • Medicine76.5%
  • Biochemistry, Genetics and Molecular Biology14.4%
  • Physics and Astronomy3.4%
  • Immunology and Microbiology1.6%
  • Computer Science1.2%
  • Engineering0.9%
  • Other2%

Topics

  • Colorectal Cancer Surgical Treatments5.4%
  • Colorectal Cancer Treatments and Studies4.6%
  • Gastric Cancer Management and Outcomes4.2%
  • Prostate Cancer Diagnosis and Treatment3.9%
  • Pancreatic and Hepatic Oncology Research3.5%
  • Esophageal Cancer Research and Treatment3.5%
  • Other74.9%

Coauthors

All papers

Open in search
  1. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , - Annals of Oncology 2022 cited by 1,382

  2. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Demetris Papamichael, George Pentheroudakis, Per Pfeiffer, Timothy Price, Cornelis J.A. Punt, Jens Ricke, A. Roth, Ramón Salazar, Werner Scheithauer, Hans‐Joachim Schmoll, Josep Tabernero, Julien Taı̈eb, Sabine Tejpar, Harpreet Wasan, Takayuki Yoshino, Aziz Zaanan, Dirk Arnold - Annals of Oncology 2016 cited by 3,449

  3. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , - Annals of Oncology 2023 cited by 511

  4. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2010 cited by 1,952

  5. Gastric cancer

    Authors: , , , , - The Lancet 2016 cited by 1,824

  6. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , - Annals of Oncology 2015 cited by 1,317

  7. Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 526

  8. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric Van Cutsem - ESMO Open 2023 cited by 161

  9. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , - Annals of Oncology 2016 cited by 1,118

  10. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karin Jordan, Andrey Meshcheryakov, Demetris Papamichail, Per Pfeiffer, Ioannis Souglakos, Serdar Turhal, Andrés Cervantes - Annals of Oncology 2012 cited by 1,534

  11. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Clinical Oncology 2021 cited by 244

  12. The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 288

  13. International consensus guidelines on Clinical Target Volume delineation in rectal cancer

    Authors: , , , , , , , , , , , , - Radiotherapy and Oncology 2016 cited by 247

  14. Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Research 2017 cited by 165

  15. Image guidance in radiation therapy for better cure of cancer

    Authors: , , , , , , , , , , - Molecular Oncology 2020 cited by 153

  16. Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

    Authors: , , , , , , , , , , , , , - Radiotherapy and Oncology 2020 cited by 177

  17. Outcome measures in multimodal rectal cancer trials

    Authors: , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 104

  18. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Critical Reviews in Oncology/Hematology 2018 cited by 96

  19. Deep learning dose prediction for IMRT of esophageal cancer: The effect of data quality and quantity on model performance

    Authors: , , , , , , - Physica Medica 2021 cited by 66

  20. Potential Molecular Mechanisms behind the Ultra-High Dose Rate “FLASH” Effect

    Authors: , , , - International Journal of Molecular Sciences 2022 cited by 42

  21. Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Jolanda van Dieren, Marieke A. Vollebergh, Johanna W. van Sandick, Paul M. Jeene, C.T. Muijs, Marije Slingerland, Francine E.M. Voncken, Henk H. Hartgrink, Geert-Jan Creemers, Maurice J.C. van der Sangen, Grard A. P. Nieuwenhuijzen, Maaike Berbée, Marcel Verheij, Bas P. L. Wijnhoven, Laurens V. Beerepoot, Nadia Haj Mohammad, Stella Mook, Jelle P. Ruurda, Piotr Kołodziejczyk, Wojciech Polkowski, Lucjan Wyrwicz, María Alsina, Manuel Pera, Tania Fleitas, Andrés Cervantes, Magnus Nilsson, Stefan Mönig, Dorothea Wagner, Matthias Gückenberger, Ewen A. Griffiths, Elizabeth Smyth, George B. Hanna, Sheraz R. Markar, M. Asif Chaudry, M. Hawkins, Edward Cheong, Richard van Hillegersberg, Peter S.N. van Rossum, Tom Rozema, Joos Heisterkamp, Markus Schaefer, E.M. Ozsahin, Jacco J. de Haan, Jan Willem van den Berg, Frédéric Duprez, Eduard Callebout, Elke Van Daele, Ulrich Hacker, Albrecht Hoffmeister, Thomas Kuhnt, Timm Denecke, Regine Kluge, Gerald W. Prager, Aysegül Ilhan‐Mutlu, Dajana Cuicchi, Andrea Ardizzoni, Camiel Rosman, Elske C. Gootjes, Heidi Rütten, Francesco Puccetti, Stefano Cascinu, N. Slim, Maria Eugenia Barrios, Maria Carmen Fernandez, Roberto Martí-Oriol, Marisol Huerta Alvaro, Almudena Vera, E. Jordá and 10 more - European Journal of Cancer 2023 cited by 53

  22. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer

    Authors: , , , , , , , , , , , - European Urology 2021 cited by 75

  23. Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 97

  24. Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics

    Authors: , , , , , , , , , , - Radiotherapy and Oncology 2019 cited by 94